AUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (Nasdaq: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, today announced results from its five-year study evaluating the effectiveness of the TOPAZ MicroDebrider to treat common tendon disorders, and concluded patients who had the minimally invasive procedure were highly satisfied with the procedure and continue to experience pain relief. Five-year study results were presented last month at the Arthroscopy Association of North America (AANA) Annual Meeting in Washington D.C.
